REQUEST A DEMO
Total
USD $0.00
Search more companies

Metimedi Sp. z o.o. (Poland)

Main Activities: Pharmacies and Drug Stores
Full name: Metimedi Sp. z o.o. Profile Updated: June 28, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Metimedi Sp. z o.o. is an enterprise based in Poland. Its main office is in Poznan. It operates in the Pharmacies and Drug Stores sector. Metimedi Sp. z o.o. was incorporated on April 09, 2021. The company’s latest financial report indicates a net sales revenue drop of 17.53% in 2025. There was a total negative growth of 21.91% in Metimedi Sp. z o.o.’s total assets over the same period. The net profit margin of Metimedi Sp. z o.o. increased by 10.83% in 2025.

Headquarters
Ul. Starowiejska 1D/7
Poznan; Wielkopolskie; Postal Code: 61-664

Contact Details: Purchase the Metimedi Sp. z o.o. report to view the information.

Website: http://metimedi.pl

Basic Information
Registered Capital:
Purchase the Metimedi Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Metimedi Sp. z o.o. report to view the information.
Incorporation Date:
April 09, 2021
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
91%
Company Performance
Financial values in the chart are available after Metimedi Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-17.53%
Total Operating Revenue
-17.42%
Operating Profit
60.72%
EBITDA
60.72%
Net Profit/Loss for the Period
60.72%
Total Assets
-21.91%
Total Equity
-24.18%
Operating Profit Margin
10.83%
Net Profit Margin
10.83%
Return on Equity (ROE)
-42.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?